• 19 Hits
  • Search Condition : Filter (MeSH = B7-H1 Antigen / metabolism*)
Species Resource Title
Human and Animal Cells NUGC-4(RCB1939) Trastuzumab upregulates programmed death ligand-1 expression through interaction with NK cells in gastric cancer.
Human and Animal Cells MIH5(RPMI)(RCB2324) The Role of Liver Sinusoidal Endothelial Cells in Induction of Carbohydrate Reactive B Cells Tolerance Through the Programmed Death 1/Programmed Death Ligand 1 Pathway.
Human and Animal Cells HGC-27(RCB0500) Helicobacter pylori cag pathogenicity island's role in B7-H1 induction and immune evasion.
Human and Animal Cells LM8(RCB1450) α1-Acid Glycoprotein Enhances the Immunosuppressive and Protumor Functions of Tumor-Associated Macrophages.
Human and Animal Cells A549 , LC-2/ad(RCB0440) , RERF-LC-KJ(RCB1313) PD-L1 overexpression is partially regulated by EGFR/HER2 signaling and associated with poor prognosis in patients with non-small-cell lung cancer.
Human and Animal Cells U-937 DE-4(RCB0435) Bu Fei Decoction attenuates the tumor associated macrophage stimulated proliferation, migration, invasion and immunosuppression of non-small cell lung cancer, partially via IL-10 and PD-L1 regulation.
Human and Animal Cells SKW-3(RCB1168) , MOLT-4(RCB0206) , 103-LCL(RCB2082) , 141-LCL(RCB2083) , DAUDI(RCB1640) , TL-1(RCB1871) , SLVL(RCB1702) , RAJI(RCB1647) , NALM-6(RCB1933) , BALL-1 An IL-27/Stat3 axis induces expression of programmed cell death 1 ligands (PD-L1/2) on infiltrating macrophages in lymphoma.
DNA material , Human and Animal Cells pCAmGCSF (RDB01522) , pCAZ 2 (RDB01870) , OV2944-HM-1(RCB1483) The role of myeloid-derived suppressor cells in increasing cancer stem-like cells and promoting PD-L1 expression in epithelial ovarian cancer.
Human and Animal Cells PC-9(RCB4455) , A549 Effect of platinum‑based chemotherapy on the expression of natural killer group 2 member D ligands, programmed cell death‑1 ligand 1 and HLA class I in non‑small cell lung cancer.
Mice RBRC04395 Breast cancer cells promote CD169+ macrophage-associated immunosuppression through JAK2-mediated PD-L1 upregulation on macrophages.
Human and Animal Cells LU65(RCB1967) PD-L1-specific helper T-cells exhibit effective antitumor responses: new strategy of cancer immunotherapy targeting PD-L1 in head and neck squamous cell carcinoma.
Human and Animal Cells A549(RCB0098) Interferon-β signal may up-regulate PD-L1 expression through IRF9-dependent and independent pathways in lung cancer cells.
Human and Animal Cells RERF-LC-AI(RCB0444) , A549 , LC-2/ad(RCB0440) Impact of COX2 Inhibitor for Regulation of PD-L1 Expression in Non-small Cell Lung Cancer.
Human and Animal Cells B16/BL6(RCB2638) In Vivo Antitumor Effects of MK615 Led by PD-L1 Downregulation.
Human and Animal Cells HLC-1(RCB0083) Nafamostat mesilate, a serine protease inhibitor, suppresses interferon-gamma-induced up-regulation of programmed cell death ligand 1 in human cancer cells.
Human and Animal Cells MIA Paca2(RCB2094) The JAK/STAT pathway is involved in the upregulation of PD-L1 expression in pancreatic cancer cell lines.
Human and Animal Cells RBE(RCB1292) , HuCCT1(RCB1960) Suppressive expression of CD274 increases tumorigenesis and cancer stem cell phenotypes in cholangiocarcinoma.
Human and Animal Cells PCM6(RCB1460) Marrow stromal cells induce B7-H1 expression on myeloma cells, generating aggressive characteristics in multiple myeloma.
Human and Animal Cells OV2944-HM-1(RCB1483) IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer.